Nanotechnology offers promising advancements in both cancer treatment and diagnosis. Nanoparticles (NPs) represent a breakthrough in cancer treatment because they target tumors precisely, improve drug delivery, and enhance imaging techniques. These nanoscale materials have the potential to reduce side ...
ARKG could, over time, prove to be highly relevant in this conversation because cancer treatment is rapidly evolving. As an actively managed fund, ARKG has the flexibility needed to keep up with the breakneck pace of genomics advancements and cancer treatments....
in PD-1/PD-L1 bispecific antibodies up to now have been summarized, and the latest findings from the 2024 ASCO conference are presented, revealing that bispecific antibodies exhibit robust efficacy in treating various types of cancers, marking a significant step forward in cancer treatment. ...
Cancer immunotherapy has emerged as a breakthrough approach in cancer treatment for eliminating minimal residual tumors by activating the inherent capacity of the immune system and improving the survival of advanced-stage patients [1,2]. Although clinical trials have achieved promising outcomes, there a...
The aim of this review is to comprehensively analyze existing studies to evaluate the therapeutic efficacy, mechanistic aspects, and clinical potential of CPT and its modified forms, including derivatives, analogues, and nanoformulations, in cancer treatment. A comprehensive literature review was ...
Explore the dynamic landscape of metastatic non-squamous non-small cell lung cancer treatment, focusing on molecular genotyping, targeted therapies, and the evolving standard of care. This is a modal window. This video is either unavailable or not supported in this browser Error Code: MEDIA_ERR_...
Chimeric antigen receptor T-cell immunotherapy (CAR-T) represents a novel approach in cancer treatment that harnesses the anti-tumor immune response. In comparison to traditional immunotherapy, CAR-T exhibits enhanced tumor antigen specificity and cell cytotoxicity independent of major histocompatibility com...
In Reply: Local Excision as an Optional Tool to Individualize Treatment of Rectal Cancer To the Editor: We are grateful for the opportunity to answer the letter of Dr. Ziogas and colleagues, 1 in which the authors pointed towards the increasin... T Borschitz - 《Annals of Surgical Oncology...
Multiple myeloma is a relatively uncommon form of blood cancer in thebone marrowthat affects less than 1% of the U.S. population, according to the American Cancer Society. While there is no cure, the disease can be treated with medication, chemotherapy, radiation and even bone marrow transplant...
And like any cancer, the sooner it's identified, the sooner we start treatment, the better everybody's outcome." Sarcomas are very specific types of cancers that represent about 1 percent of cancers in adults. "It's important to increase awareness around sarcomas because they occur in ...